rs12692386
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003183.6(ADAM17):c.-172T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.656 in 500,398 control chromosomes in the GnomAD database, including 114,008 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.71 ( 40565 hom., cov: 33)
Exomes 𝑓: 0.63 ( 73443 hom. )
Consequence
ADAM17
NM_003183.6 5_prime_UTR
NM_003183.6 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.89
Genes affected
ADAM17 (HGNC:195): (ADAM metallopeptidase domain 17) This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biologic processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. The encoded preproprotein is proteolytically processed to generate the mature protease. The encoded protease functions in the ectodomain shedding of tumor necrosis factor-alpha, in which soluble tumor necrosis factor-alpha is released from the membrane-bound precursor. This protease also functions in the processing of numerous other substrates, including cell adhesion proteins, cytokine and growth factor receptors and epidermal growth factor (EGF) receptor ligands, and plays a prominent role in the activation of the Notch signaling pathway. Elevated expression of this gene has been observed in specific cell types derived from psoriasis, rheumatoid arthritis, multiple sclerosis and Crohn's disease patients, suggesting that the encoded protein may play a role in autoimmune disease. Additionally, this protease may play a role in viral infection through its cleavage of ACE2, the cellular receptor for SARS-CoV and SARS-CoV-2. [provided by RefSeq, Aug 2020]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 2-9555777-A-G is Benign according to our data. Variant chr2-9555777-A-G is described in ClinVar as [Benign]. Clinvar id is 1227372.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.927 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAM17 | NM_003183.6 | c.-172T>C | 5_prime_UTR_variant | Exon 1 of 19 | ENST00000310823.8 | NP_003174.3 | ||
ADAM17 | NM_001382777.1 | c.-852T>C | 5_prime_UTR_variant | Exon 1 of 19 | NP_001369706.1 | |||
ADAM17 | NM_001382778.1 | c.-1094T>C | 5_prime_UTR_variant | Exon 1 of 19 | NP_001369707.1 | |||
ADAM17 | XM_047445610.1 | c.-330T>C | 5_prime_UTR_variant | Exon 1 of 20 | XP_047301566.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAM17 | ENST00000310823.8 | c.-172T>C | 5_prime_UTR_variant | Exon 1 of 19 | 1 | NM_003183.6 | ENSP00000309968.3 | |||
ADAM17 | ENST00000618923.2 | n.-172T>C | non_coding_transcript_exon_variant | Exon 1 of 8 | 1 | ENSP00000480552.1 | ||||
ADAM17 | ENST00000618923.2 | n.-172T>C | 5_prime_UTR_variant | Exon 1 of 8 | 1 | ENSP00000480552.1 |
Frequencies
GnomAD3 genomes AF: 0.709 AC: 107826AN: 152034Hom.: 40515 Cov.: 33
GnomAD3 genomes
AF:
AC:
107826
AN:
152034
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.633 AC: 220428AN: 348248Hom.: 73443 Cov.: 5 AF XY: 0.634 AC XY: 114016AN XY: 179884
GnomAD4 exome
AF:
AC:
220428
AN:
348248
Hom.:
Cov.:
5
AF XY:
AC XY:
114016
AN XY:
179884
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.709 AC: 107924AN: 152150Hom.: 40565 Cov.: 33 AF XY: 0.694 AC XY: 51653AN XY: 74398
GnomAD4 genome
AF:
AC:
107924
AN:
152150
Hom.:
Cov.:
33
AF XY:
AC XY:
51653
AN XY:
74398
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1579
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Nov 10, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Mycobacterium tuberculosis, susceptibility to Uncertain:1
Dec 21, 2023
Laboratory Of Immunobiology And Genetics, Instituto Nacional De Enfermedades Respiratorias Ismael Cosio Villegas
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: research
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at